1. Home
  2. CCO vs EYPT Comparison

CCO vs EYPT Comparison

Compare CCO & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clear Channel Outdoor Holdings Inc.

CCO

Clear Channel Outdoor Holdings Inc.

HOLD

Current Price

$2.33

Market Cap

1.2B

ML Signal

HOLD

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$14.58

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCO
EYPT
Founded
1995
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2005
2005

Fundamental Metrics

Financial Performance
Metric
CCO
EYPT
Price
$2.33
$14.58
Analyst Decision
Hold
Strong Buy
Analyst Count
5
5
Target Price
$2.12
$31.80
AVG Volume (30 Days)
7.3M
1.7M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
110.81
N/A
EPS
N/A
N/A
Revenue
$1,604,140,000.00
$7,539,000.00
Revenue This Year
$5.35
N/A
Revenue Next Year
$4.26
$3,115.57
P/E Ratio
N/A
N/A
Revenue Growth
6.57
N/A
52 Week Low
$1.16
$9.65
52 Week High
$2.44
$19.11

Technical Indicators

Market Signals
Indicator
CCO
EYPT
Relative Strength Index (RSI) 32.05 59.30
Support Level $2.33 $11.86
Resistance Level $2.41 $15.01
Average True Range (ATR) 0.03 0.88
MACD -0.01 0.20
Stochastic Oscillator 25.00 97.48

Price Performance

Historical Comparison
CCO
EYPT

About CCO Clear Channel Outdoor Holdings Inc.

Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

Share on Social Networks: